Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Vivos Therapeutics Inc VVOS

Healthcare
Vivos Therapeutics, Inc. is a medical technology company focused on developing and commercializing diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as obstructive sleep apnea (OSA) and snoring in adults. The Company calls its solution The Vivos Method. The Vivos Method represents the first clinically... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:VVOS)

Vivos Therapeutics Reports Third Quarter 2024 Financial Results and Provides Operational Update

GlobeNewswire 10 days ago

Vivos Therapeutics Schedules Release of Third Quarter 2024 Financial Results and Conference Call

GlobeNewswire 11 days ago

Vivos Therapeutics Granted CPT® Coverage and Reimbursement Codes for All Vivos CARE Oral Medical Devices From American Medical Association

GlobeNewswire October 8, 2024

Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules

GlobeNewswire September 19, 2024

Vivos Therapeutics Receives Groundbreaking FDA 510(k) Clearance to Treat Moderate to Severe Pediatric Sleep Apnea and Snoring

GlobeNewswire September 18, 2024

Vivos Therapeutics Reports Second Quarter 2024 Financial Results and Provides Operational Update

GlobeNewswire August 14, 2024

Vivos Therapeutics Schedules Release of Second Quarter 2024 Financial Results and Conference Call

GlobeNewswire August 14, 2024

Vivos Therapeutics Announces Positive Results From 7-Month Multi-Site Pilot of its New Provider-Based Marketing and Distribution Model

GlobeNewswire June 27, 2024

Vivos Therapeutics Closes $7.5 Million At-The-Market Private Equity-Backed Investment and Launches Strategic Marketing and Distribution Alliance

GlobeNewswire June 12, 2024
View More News ››

Opinion & Analysis (NDAQ:VVOS)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:VVOS)

VVOS......I'll say it another time ; )

You've all been had ........ AGAIN !!!!!!!!!!!!!!!!!!!!!!
Iseneschal - September 19, 2024

RE:VVOS.....Early a.m runner on NR

And you thought I was just joking?????   Vivos Therapeutics Announces Pricing of $4.3 Million Registered Direct Offering of...
Iseneschal - September 19, 2024

RE:VVOS....Crash Boom Bang....now at the opening price

It rallied....albeit.....briefly.......Now back to where it could just completely tank . JMHO....currently at $3.56
Iseneschal - September 18, 2024

VVOS....Crash Boom Bang....now at the opening price

Better rally from here or it's all over but the crying $3.45
Iseneschal - September 18, 2024

VVOS.....Early a.m runner on NR

You might think the volume & price action is related to this a.m's NR..... Vivos Therapeutics Receives Groundbreaking FDA 510...
Iseneschal - September 18, 2024

Vivos Therapeutics, Inc. (NASDAQ:VVOS): Innovative Sleep Apn

http://beyondspx.com/2024/08/02/vivos-therapeutics-inc-nasdaqvvos-innovative-sleep-apnea-treatment-poised-for-significant-growth/
MikeTester - August 3, 2024
View more Bullboard ››

Viva Gold Corp.

Viva Gold Corp.

Viva Gold Corp. is a Canada-based gold exploration and development company, The Company’s business is the acquisition ...
View More »